Premises approved
Drugs approved
assisting treating therapists approved
Treating Psychiatrists approved
Excellent milestone achievement setting a new benchmark in addressing unmet need
Congratulations to the company and the Australian Therapeutic Goods Administration for establishing a landmark outcome globally in the treatment of depressive disorders by way of psychedelic micro dosing.
